February 25, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45 th Annual Health Care Conference on Tuesday, Mar. 4 ...

Jones Financial Companies Lllp lifted its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 19.9% during the ...

I am optimistic about the tremendous opportunities in front of us to transform structural heart patient care ... found at edwards.com. Edwards, Edwards Lifesciences, the stylized E logo, EARLY ...

Becton, Dickinson and Co. (BD) has appointed longtime Edwards Lifesciences sales and marketing exec Tim Patz as the new ...

IRVINE, Calif., February 25, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45 th Annual Health Care Conference on Tuesday, Mar.

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion ...

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care Conference on Tuesday, Mar. 4, 2025. Scott Ullem, chief financial officer ...

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers ...

He emphasized the success of strategic decisions in 2024, including the sale of the Critical Care business ... could affect adoption rates. Edwards Lifesciences concluded 2024 with strong ...